세계의 메타게놈 시퀀싱 시장 : 제품 및 서비스, 워크플로우, 기술, 용도별 예측(2025-2030년)

The Metagenomic Sequencing Market was valued at USD 2.15 billion in 2023, expected to reach USD 2.39 billion in 2024, and is projected to grow at a CAGR of 12.43%, to USD 4.89 billion by 2030.

Metagenomic sequencing is a revolutionary approach in genomics that analyzes the genetic material from environmental samples, enabling the comprehensive study of microbial communities without the need for culturing. This approach is crucial for understanding complex microbiomes in environments such as soil, oceans, and human gut flora. Its applications span multiple fields, including clinical diagnostics, where it aids in detecting pathogen outbreaks, agriculture for soil health assessment, and bioremediation efforts to clean pollutants. The end-use scope extends across pharmaceutical industries, environmental agencies, academic research institutions, and healthcare. Market growth is driven by technological advancements in sequencing technologies, growing awareness about microbiomes' roles in health, and increased investment in research and development. Emerging opportunities lie in personalized medicine, where metagenomics can offer tailored health solutions based on individual microbiome compositions, and in agriculture, providing sustainable crop management solutions. Challenges include high costs, data analysis complexity, and limited reference databases, which can impede data interpretation. Addressing these challenges through innovation in bioinformatics tools, reducing sequencing costs, and enhancing cross-industry collaborations could facilitate market expansion. Key areas for research innovation include developing faster, more cost-effective sequencing technologies and predictive analytics to interpret complex metagenomic data accurately. The market is characterized by rapid technological evolution, leading to a highly competitive landscape as companies strive to offer differentiated solutions. Recommendations for businesses looking to capitalize on this market involve investing in R&D for advanced sequencing platforms, forming strategic alliances for technology exchange, and focusing on expanding service offerings to include comprehensive microbiome profiling and interpretation services. Overall, the integration of metagenomic sequencing in various sectors highlights its transformative potential, but market participants must navigate challenges and leverage opportunities for sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Metagenomic Sequencing Market

The Metagenomic Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising need for the evaluation of bacterial diversity and detection of various microbes
  • Growing prevalence of genetic disorders worldwide
  • Rising investment by government and private sector for sequencing projects
• Market Restraints
  • Limited storage for the sequencing data
  • High price for the end-user in developing countries
• Market Opportunities
  • Technological advancement for the metagenomic sequencing data management
  • Technological development for better metagenomic sequencing
• Market Challenges
  • Dearth of skilled and experienced workforce

Porter's Five Forces: A Strategic Tool for Navigating the Metagenomic Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Metagenomic Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Metagenomic Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Metagenomic Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Metagenomic Sequencing Market

A detailed market share analysis in the Metagenomic Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Metagenomic Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Metagenomic Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Metagenomic Sequencing Market

A strategic analysis of the Metagenomic Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Metagenomic Sequencing Market, highlighting leading vendors and their innovative profiles. These include Azenta US, Inc., BGI Genomics Co., Ltd., CosmosID, DNASTAR, Inc., Eurofins Genomics Germany GmbH, Freenome Holdings, Inc., IntegraGen S.A., Macrogen Europe BV, Microsynth AG, Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PerkinElmer Inc., Psomagen, Inc., and QIAGEN GmbH.

Market Segmentation & Coverage

This research report categorizes the Metagenomic Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables, and Services.
• Based on Workflow, market is studied across Data Processing & Analysis, Sample Processing & Library Preparation, and Sequencing.
• Based on Technology, market is studied across 16S rRNA Sequencing, Metatranscriptomics, Shotgun Metagenomic Sequencing, and Whole-genome Sequencing & De Novo Assembly.
• Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, Ecological & Environmental Applications, Industrial applications, Soil Microbiome Applications, and Veterinary Applications.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising need for the evaluation of bacterial diversity and detection of various microbes
    • 5.1.1.2. Growing prevalence of genetic disorders worldwide
    • 5.1.1.3. Rising investment by government and private sector for sequencing projects
  • 5.1.2. Restraints
    • 5.1.2.1. Limited storage for the sequencing data
    • 5.1.2.2. High price for the end-user in developing countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement for the metagenomic sequencing data management
    • 5.1.3.2. Technological development for better metagenomic sequencing
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled and experienced workforce
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Metagenomic Sequencing Market, by Product & Service

• 6.1. Introduction
• 6.2. Analysis & Data Interpretation Solutions
• 6.3. Instruments
• 6.4. Reagents & Consumables
• 6.5. Services

7. Metagenomic Sequencing Market, by Workflow

• 7.1. Introduction
• 7.2. Data Processing & Analysis
• 7.3. Sample Processing & Library Preparation
• 7.4. Sequencing

8. Metagenomic Sequencing Market, by Technology

• 8.1. Introduction
• 8.2. 16S rRNA Sequencing
• 8.3. Metatranscriptomics
• 8.4. Shotgun Metagenomic Sequencing
• 8.5. Whole-genome Sequencing & De Novo Assembly

9. Metagenomic Sequencing Market, by Application

• 9.1. Introduction
• 9.2. Clinical Diagnostics
• 9.3. Drug Discovery
• 9.4. Ecological & Environmental Applications
• 9.5. Industrial applications
• 9.6. Soil Microbiome Applications
• 9.7. Veterinary Applications

10. Americas Metagenomic Sequencing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Metagenomic Sequencing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Metagenomic Sequencing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Azenta US, Inc.
• 2. BGI Genomics Co., Ltd.
• 3. CosmosID
• 4. DNASTAR, Inc.
• 5. Eurofins Genomics Germany GmbH
• 6. Freenome Holdings, Inc.
• 7. IntegraGen S.A.
• 8. Macrogen Europe BV
• 9. Microsynth AG
• 10. Novogene Co., Ltd.
• 11. Oxford Nanopore Technologies PLC
• 12. Pacific Biosciences of California, Inc.
• 13. PerkinElmer Inc.
• 14. Psomagen, Inc.
• 15. QIAGEN GmbH